MIR4278: A Drug Target / Disease Biomarker (G100422999)
![Review Report on MIR4278 Target / Biomarker](https://silexon.ai/img/target-biomarker-review.jpg?a=1)
![Content of Review Report on MIR4278 Target / Biomarker](https://silexon.ai/img/target-biomarker-review-content.jpg?a=2)
MIR4278: A Drug Target / Disease Biomarker
MIR4278 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is miR-4278, and it is a microRNA (miRNA) that plays a critical role in gene expression regulation.
MiR-4278 is a non-coding RNA molecule that is around 200 nucleotides long. It is made up of four exons, which are the first four amino acids that make up the protein. The full-length sequence of MIR-4278 is as follows:
GAA GAA GAG GAA
GAA GAA UAUG UAA
GAA GAA GAG GAA
GAA GAA UAUG UAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
GAA GAA GAG GAA
GAA GAA UAUG UAA
GAA GAA GAG GAA
GAA GAA UAUG UAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
GAA GAA GAG GAA
GAA GAA UAUG UAA
GAA GAA GAG GAA
GAA GAA UAUG UAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA UAAUG GAA
UAA U
Protein Name: MicroRNA 4278
The "MIR4278 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4278 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4279 | MIR4280 | MIR4281 | MIR4282 | MIR4283-1 | MIR4283-2 | MIR4284 | MIR4285 | MIR4286 | MIR4287 | MIR4288 | MIR4289 | MIR429 | MIR4290 | MIR4291 | MIR4292 | MIR4293 | MIR4294 | MIR4295 | MIR4296 | MIR4297 | MIR4298 | MIR4299 | MIR4300 | MIR4300HG | MIR4301 | MIR4302 | MIR4303 | MIR4304 | MIR4305 | MIR4306 | MIR4307 | MIR4308 | MIR4309 | MIR431 | MIR4310 | MIR4311 | MIR4312 | MIR4313 | MIR4314 | MIR4315-1 | MIR4315-2 | MIR4316 | MIR4317 | MIR4318 | MIR4319 | MIR432 | MIR4320 | MIR4321 | MIR4322 | MIR4323 | MIR4324 | MIR4325 | MIR4326 | MIR4327 | MIR4328 | MIR4329 | MIR433 | MIR4330 | MIR4418 | MIR4420 | MIR4423 | MIR4425 | MIR4427 | MIR4428 | MIR4429 | MIR4430 | MIR4431 | MIR4432 | MIR4432HG | MIR4433A | MIR4433B | MIR4435-1 | MIR4435-2 | MIR4435-2HG | MIR4436A | MIR4436B1 | MIR4436B2 | MIR4437 | MIR4440 | MIR4441 | MIR4442 | MIR4443 | MIR4444-1 | MIR4444-2 | MIR4445 | MIR4446 | MIR4447 | MIR4448 | MIR4449 | MIR4450 | MIR4451 | MIR4453 | MIR4453HG | MIR4454 | MIR4455 | MIR4456 | MIR4457 | MIR4458 | MIR4458HG